Medcorp Limited (TTSE:MED)
Trinidad and Tobago · Delayed Price · Currency is TTD 38.00
0.00 (0.00%)
At close: Aug 14, 2026
Medcorp Income Statement
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122.54 | 121.7 | 122.24 | 127.02 | 122.22 | 114.19 | |
Revenue Growth | -1.23% | -0.44% | -3.76% | 3.92% | 7.03% | 10.46% |
Cost of Revenue | 60.69 | 60.03 | 59.68 | 56 | 61.81 | 56.05 |
Gross Profit | 61.85 | 61.67 | 62.55 | 71.02 | 60.41 | 58.14 |
Selling, General & Admin | 41.69 | 41.04 | 38.64 | 33.24 | 32.08 | 28.4 |
Other Operating Expenses | -1.52 | -1.68 | 0.55 | -1.66 | -3.19 | -5.25 |
Operating Expenses | 40.17 | 39.36 | 39.19 | 31.59 | 28.89 | 23.15 |
Operating Income | 21.68 | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 |
Interest Expense | -4.02 | -4.34 | -5.95 | -3.21 | -2.45 | -2.31 |
Interest & Investment Income | - | - | - | 30.69 | - | - |
Earnings From Equity Investments | 2.51 | 2.45 | 4.83 | 4.98 | 1.72 | 1.99 |
EBT Excluding Unusual Items | 20.18 | 20.42 | 22.24 | 71.89 | 30.79 | 34.66 |
Gain (Loss) on Sale of Assets | - | - | - | -0 | 0.12 | - |
Pretax Income | 20.18 | 20.42 | 22.24 | 71.89 | 30.91 | 34.66 |
Income Tax Expense | 0.62 | 2.24 | 6.86 | 14.82 | 6.78 | 10.17 |
Net Income | 19.56 | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 |
Net Income to Common | 19.56 | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 |
Net Income Growth | 37.45% | 18.21% | -73.05% | 136.53% | -1.49% | 38.74% |
Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Change | 2.94% | 2.34% | - | - | - | - |
EPS (Basic) | 2.54 | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 |
EPS (Diluted) | 2.54 | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 |
EPS Growth | 33.52% | 15.51% | -73.05% | 136.53% | -1.49% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 14.35 | 22.76 | 20.12 | 28.71 | 25.41 | 5.66 |
Free Cash Flow Per Share | 1.86 | 2.97 | 2.69 | 3.84 | 3.40 | 0.76 |
Dividend Per Share | 2.000 | 2.000 | 4.000 | - | - | 4.500 |
Dividend Growth | -50.00% | -50.00% | - | - | - | - |
Gross Margin | 50.48% | 50.67% | 51.17% | 55.92% | 49.43% | 50.91% |
Operating Margin | 17.69% | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% |
Profit Margin | 15.96% | 14.94% | 12.58% | 44.93% | 19.74% | 21.45% |
Free Cash Flow Margin | 11.71% | 18.70% | 16.46% | 22.60% | 20.79% | 4.96% |
EBITDA | 25.33 | 27.05 | 28.55 | 44.62 | 36.67 | 36.91 |
EBITDA Margin | 20.67% | 22.23% | 23.36% | 35.13% | 30.00% | 32.32% |
D&A For EBITDA | 3.65 | 4.74 | 5.19 | 5.18 | 5.14 | 1.92 |
EBIT | 21.68 | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 |
EBIT Margin | 17.69% | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% |
Effective Tax Rate | 3.05% | 10.96% | 30.86% | 20.62% | 21.94% | 29.34% |
Advertising Expenses | - | 0.28 | 0.24 | 0.17 | 0.2 | 0.14 |